Insiders who reported open-market trades in the last 12 months at the companies Lisa Ricciardi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
John Brendan Doyle - $11K in CGTX purchases and sales in the last 12 months
Anthony Caggiano - $11K in CGTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Lisa Ricciardi is a corporate insider, tracked as CEO & President, Director of COGNITION THERAPEUTICS INC (CGTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lisa Ricciardi last file a Form 4?
The most recent primary Form 4 on record is dated 20 April 2026, one of 4 filings going back to 2025.
Has Lisa Ricciardi been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10K) and 0 open-market sales across all tracked filings.
Lisa Ricciardi is CEO & President, Director of COGNITION THERAPEUTICS INC (CGTX). 4 SEC Form 4 filings on record going back to 2025, most recently on 20 April 2026. Most recent open-market trade: bought $10K of CGTX on 20 April 2026. Lifetime open-market purchases: $10K.
Recent transactions
7
The latest 7 SEC Form 4 transactions reported by Lisa Ricciardi.
InsiderAlpha's records for Lisa Ricciardi go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $10K (1 buy totaling $10K). The largest single buy on record is $10K of CGTX in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
